tm logo

Monitor this mark

View On USPTO

NALFURAPRANT
Live/Pending
PUBLISHED FOR OPPOSITION

on 17 Dec 2024

Last Applicant/ Owned by

Jaywing Therapeutics

8530 Sand Point Way NE

Seattle

WA

98115-3950

Serial Number

98438274 filed on 07th Mar 2024

Registration Number

N/A

Correspondent Address

Seattle, WA 98115-3950

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NALFURAPRANT

Pharmaceutical preparations for the treatment and prevention of addiction, psychosis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment and prevention of addiction, psychosis

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98438274

Mark Type

No Service/Collective Mark

Attorney Docket Number

No N/A

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Dec 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Dec 2024PUBLISHED FOR OPPOSITION
11th Dec 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Nov 2024ASSIGNED TO LIE
21st Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
20th Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
20th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
22nd Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
20th Sep 2024ASSIGNED TO EXAMINER
20th Sep 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED